Prime Medicine (PRME) Deferred Taxes (2021 - 2024)
Prime Medicine (PRME) posted Deferred Taxes of -$134000.0 for Q2 2024, down 200.0% on a QoQ basis from $134000.0 in Q1 2024, and down 532.26% year-over-year from $31000.0 in Q3 2023.
Prime Medicine (PRME) Deferred Taxes (2021 - 2024) Analysis & Trends
Prime Medicine's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$134000.0 for Q2 2024.
- Quarterly Deferred Taxes fell 532.26% year-over-year to -$134000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$134000.0 (down 335.09% YoY) and the FY2023 annual result came in at -$279000.0, up 71.06% from the prior year.
- Deferred Taxes was -$134000.0 for Q2 2024 at Prime Medicine, down from $134000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $1.2 million in Q4 2021 and bottomed at -$532000.0 in Q1 2022.
- A 4-year average of $0.0 and a median of -$121000.0 in 2023 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 166.34% in 2024, while the deepest fall reached 532.26% in 2024.
- Prime Medicine's Deferred Taxes stood at $1.2 million in 2021, then tumbled by 116.25% to -$202000.0 in 2022, then surged by 46.53% to -$108000.0 in 2023, then dropped by 24.07% to -$134000.0 in 2024.
- Business Quant data shows PRME's Deferred Taxes at -$134000.0 in Q2 2024, $134000.0 in Q1 2024, and -$108000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Prime Medicine | 524.20 Mn | 524.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -134,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Sep 30, 2023 | -108,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | -202,000.00 |
| Dec 31, 2022 | -202,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -532,000.00 |
| Dec 31, 2021 | 1.24 Mn |